Wells Fargo’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.7K | Buy |
38,326
+38,159
| +22,850% | +$74.4K | ﹤0.01% | 4946 |
|
|
2025
Q1 | $366 | Hold |
167
| – | – | ﹤0.01% | 5820 |
|
|
2024
Q4 | $543 | Hold |
167
| – | – | ﹤0.01% | 5802 |
|
|
2024
Q3 | $217 | Hold |
167
| – | – | ﹤0.01% | 5813 |
|
|
2024
Q2 | $202 | Sell |
167
-40
| -19% | -$48 | ﹤0.01% | 5817 |
|
|
2024
Q1 | $447 | Buy |
207
+6
| +3% | +$13 | ﹤0.01% | 5911 |
|
|
2023
Q4 | $255 | Sell |
201
-31
| -13% | -$39 | ﹤0.01% | 6099 |
|
|
2023
Q3 | $322 | Buy |
232
+36
| +18% | +$50 | ﹤0.01% | 6083 |
|
|
2023
Q2 | $707 | Buy |
196
+4
| +2% | +$14 | ﹤0.01% | 6099 |
|
|
2023
Q1 | $759 | Buy |
192
+169
| +735% | +$668 | ﹤0.01% | 6130 |
|
|
2022
Q4 | $68 | Buy |
23
+1
| +5% | +$3 | ﹤0.01% | 6581 |
|
|
2022
Q3 | $0 | Hold |
22
| – | – | ﹤0.01% | 6641 |
|
|
2022
Q2 | $0 | Buy |
22
+2
| +10% | – | ﹤0.01% | 6800 |
|
|
2022
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 6922 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 6915 |
|
|
2021
Q3 | $0 | Buy |
20
+18
| +900% | – | ﹤0.01% | 6856 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 6760 |
|
|
2021
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6698 |
|